Long Bai

Dr. Long Bai


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SFShujun Feng
Shujun Feng
SWShan Wan
Shan Wan
SLShuangying Liu
Shuangying Liu
WWWei Wang
Wei Wang
MTMinyue Tang
Minyue Tang
YZYi-Min Zhu
Yi-Min Zhu
Several studies have indicated that mutations of LARS2 are associated with premature ovarian insufficiency (POI). However, the pathogenic mechanism of LARS2 in POI has not been reported yet. In the present study, the expression levels of LARS2 and E2F1 in granulosa cells (GCs) of POI patients were examined. CCK‐8 and Edu assay were performed to determine the effect of LARS2 on cell proliferation. Apoptosis rate, mitochondrial membrane potential, reactive oxygen species (ROS), and cytoplasm Ca2+ levels were analyzed by flow cytometry. Western blot was conducted to evaluate the expression level of genes affected by LARS2. Transmission electron microscopy (TEM) was used to observe mitochondrial structure in GCs. Chromatin immunoprecipitation (ChIP) was used to evaluate the regulatory effect of E2F1 on Mfn‐2 expression. Our results showed that LARS2 expression was downregulated in GCs of POI patients. Silencing of LARS2 inhibited cell proliferation and promoted the apoptosis of GCs. Meanwhile, LARS2 knockdown could induce mitochondrial dysfunction and accumulation of ROS levels. Moreover, ROS was found to be involved in the antiproliferation, proapoptotic, and endoplasmic reticulum (ER) stress effects of LARS2 knockdown. Furthermore, we also found that the expression level of E2F1 was positively correlated with LARS2. In addition, E2F1 could bind at the ‐61/‐46 region of Mfn‐2 promoter and regulated MFN‐2 transcription. These findings demonstrated that LARS2 could promote the expression of E2F1. E2F1 mediated the effect of LARS2 on Mfn‐2 expression via targeting the promoter region of Mfn‐2, in which subsequently regulated cell proliferation and apoptosis, which resulted in the etiology of POI. This study will provide useful information for further investigations on the LARS2 in the occurrence of POI.

17 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LBLong Bai
Long Bai
YXYu Xiang
Yu Xiang
MTMinyue Tang
Minyue Tang
SLShuangying Liu
Shuangying Liu
QCQingqing Chen
Qingqing Chen
YZYi-Min Zhu
Yi-Min Zhu
N6-methyladenosine (m6A) maintains maternal RNA stability in oocytes. One regulator of m6A, ALKBH5, reverses m6A deposition and is essential in RNA metabolism. However, the specific role of ALKBH5 in oocyte maturation remains elusive. Here, we show that Alkbh5 depletion causes a wide range of defects in oocyte meiosis and results in female infertility. Temporal profiling of the maternal transcriptomes revealed striking RNA accumulation in Alkbh5−/− oocytes during meiotic maturation. Analysis of m6A dynamics demonstrated that ALKBH5-mediated m6A demethylation ensures the timely degradation of maternal RNAs, which is severely disrupted following Alkbh5−/− depletion. A distinct subset of transcripts with persistent m6A peaks are recognized by the m6A reader IGF2BP2 and thus remain stabilized, resulting in impaired RNA clearance. Additionally, reducing IGF2BP2 in Alkbh5-depleted oocytes partially rescued these defects. Overall, this work identifies ALKBH5 as a key determinant of oocyte quality and unveil the facilitating role of ALKBH5-mediated m6A removal in maternal RNA decay.

1 March 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
LBLong Bai
Long Bai
WWWei Wang
Wei Wang
YXYu Xiang
Yu Xiang
SWShuyi Wang
Shuyi Wang
SWShan Wan
Shan Wan
YZYi-Min Zhu
Yi-Min Zhu
Clinical investigations have demonstrated that polycystic ovary syndrome (PCOS) is often accompanied by insulin resistance (IR) in more than 70% of women with PCOS. However, the etiology of PCOS with IR remains to be characterized. Growth differentiation factor 8 (GDF8) is an intraovarian factor that plays a vital role in the regulation of follicle development and ovulation. Previous studies have reported that GDF8 is a pathogenic factor in glucose metabolism disorder in IR patients. To date, the role of GDF8 on glucose metabolism of granulosa cell in PCOS patients remains to be determined. In the current study, we demonstrated that the expression and accumulation of GDF8 in human granulosa-lutein (hGL) cells and follicular fluid from PCOS patients were higher compared with those of non-PCOS women. GDF8 treatment caused glucose metabolism defects in hGL cells. Transcriptome sequencing results showed that SERPINE1 mediated GDF8-induced impairment of hGL glucose metabolism defects. Using pharmacological and small interfering RNA (siRNA)-mediated knockdown approaches, we demonstrated that GDF8 upregulated the expression of SERPINE1 via the ALK5-mediated SMAD2/3-SMAD4 signaling pathway. Interestingly, the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway was also activated with GDF8 treatment but did not participate in the effect of GDF8 on SERPINE1 expression. Our results also showed that TP53 was required for the GDF8-stimulated increase in SERPINE1 expression. Importantly, our study demonstrated that SB-431542 treatment significantly improved DHEA-induced PCOS-like ovaries. These findings support a potential role for GDF8 in metabolic disorders in PCOS.

27 March 2025 in Human Reproduction Update
Verified
Journal Article
Closed access
YXYu Xiang
Yu Xiang
HCHsun-Ming Chang
Hsun-Ming Chang
PLPeter C. K. Leung
Peter C. K. Leung
LBLong Bai
Long Bai
YZYi-Min Zhu
Yi-Min Zhu
BACKGROUND: RNA modifications, collectively known as the epitranscriptome, represent the third layer of gene regulation, influencing gene expression at transcriptional, post-transcriptional, and translational levels. RNA-modifying proteins (RMPs), including writers, erasers, and readers, are responsible for depositing, removing, and recognizing chemical modifications on RNA molecules. These modifications play a crucial role in linking molecular processes to cellular functions. Over the past few decades, a growing body of laboratory evidence, alongside advances in sequencing technologies, has uncovered connections between aberrant RNA modifications and reproductive disorders, highlighting their emerging roles in female fertility. Given the rapid expansion of epitranscriptomic research in female reproduction, a comprehensive review is needed to summarize the broader impacts of various RNA modifications, rather than focusing on individual RNA modifications alone. OBJECTIVE AND RATIONALE: This review aims to elucidate the progress in understanding the role of RNA modifications in reproductive biology and how their dysregulations contribute to infertility-related conditions, such as polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), and endometriosis. Special focus will be given to RNA modifications in coding RNAs, particularly those linked to female fertility and supported by solid evidence. The ultimate objective is to explore how targeting the RNA-modification machinery can lead to the development of novel therapeutic interventions for restoring fertility. SEARCH METHODS: We conducted a thorough review of peer-reviewed original research articles and reviews published over the past two decades using the PubMed search engine. Keywords included terms related to RNA modifications, such as ‘N6-methyladenosine (m6A)’, ‘N4-acetylcytidine (ac4C)’, and ‘adenosine-to-inosine (A–I) editing’, combined with terms related to female reproduction, such as ‘ovary’, ‘oocyte’, and ‘embryo’. Additional relevant search phrases were also utilized to ensure comprehensive coverage of the topic. OUTCOMES: RNA modification has emerged as a transformative area in reproductive biology, with our understanding of the epitranscriptome growing rapidly due to significant advances in high-throughput sequencing technologies. Regulatory proteins play a crucial role in the correct deposition and functional implementation of RNA modifications. Knockout animal models have identified a broad, though still incomplete, list of RNA modifications involved in mammalian reproductive processes. These include prevalent modifications in mRNA, such as m6A, as well as A–I editing, and, to a lesser extent, 5-methylcytosine (m5C) and ac4C. These regulatory mechanisms impact various reproductive functions, including folliculogenesis, oocyte maturation, fertilization, and embryo development. Dysregulation of RNA modifications may exacerbate infertility-related conditions, such as POI, PCOS, and endometriosis. Although clinical investigations are still in their early stages, RNA modifications show great promise as diagnostic biomarkers and therapeutic targets, with the potential to improve fertility and reproductive health outcomes. WIDER IMPLICATIONS: This review explores a relatively underexamined area of epitranscriptomic research in female reproduction, offering the potential to significantly advance our understanding of reproductive biology. It underscores the clinical relevance of RNA modifications in infertility-related disorders and identifies potential biomarkers, as well as RMP-targeted therapies, that could shape future clinical decision-making and personalized treatments. These insights are crucial for reproductive clinicians and embryologists, presenting new avenues for diagnosis and therapeutic interventions in reproductive medicine. REGISTRATION NUMBER: N/A.

6 March 2025 in Nature Communications
Verified
Journal Article
Open access
XJXiaofei Jiao
Xiaofei Jiao
ZLZhongyang Liang
Zhongyang Liang
JLJiwei Li
Jiwei Li
LBLong Bai
Long Bai
JXJun Xu
Jun Xu
LLLin-Yu Lu
Lin-Yu Lu
Chromosome synapsis is an evolutionarily conserved process essential for meiotic recombination. HORMAD1 and HORMAD2, which monitor chromosome asynapsis by localizing to unsynapsed chromosome axes, are removed from synapsed chromosome axes by TRIP13, though the biological significance of this process remains unclear. We show that when HORMAD1 and HORMAD2 are retained on synapsed chromosome axes, they recruit BRCA1, activate chromosome asynapsis checkpoint, and trigger oocyte elimination. Unexpectedly, N-terminal tagging retains HORMAD1 and HORMAD2 on synapsed chromosome axes without triggering oocyte elimination due to defective BRCA1 recruitment. Mechanistically, HORMAD1 co-immunoprecipitates with BRCA1 readily, not through the canonical closure motif-binding mode but via an interface on its HORMA domain near the N-terminus. HORMAD2 co-immunoprecipitates with BRCA1 weakly but also regulates its recruitment. Collectively, the TRIP13-dependent removal of HORMAD1 and HORMAD2 from synapsed chromosome axes is essential for female fertility, preventing aberrant chromosome asynapsis checkpoint activation and unintended oocyte elimination.

17 February 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
SWShan Wan
Shan Wan
QCQingqing Chen
Qingqing Chen
YXYu Xiang
Yu Xiang
YSYimiao Sang
Yimiao Sang
MTMinyue Tang
Minyue Tang
YZYi-Min Zhu
Yi-Min Zhu